Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/20/2003US20030055266 Small molecule modulators of G protein-coupled receptors
03/20/2003US20030055257 Water-soluble rhodamine dye conjugates
03/20/2003US20030055239 Human receptor tyrosine kinase, KDR
03/20/2003US20030055236 Secreted protein HKABT24
03/20/2003US20030055233 Gradient resolved information platform
03/20/2003US20030055224 Antibody for use in the treatment of tumor disorders
03/20/2003US20030055222 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030055220 Protein complex for use in the diagnosis and prevention of bacterial infections
03/20/2003US20030055219 Protein-protein interactions
03/20/2003US20030055217 Peptides derived from STEAP1
03/20/2003US20030055216 Nucleotide sequences coding polypeptide for use in the treatment of tumors
03/20/2003US20030055114 Methods and compositions for inhibiting the proliferation of prostate cancer cells
03/20/2003US20030055108 Contacting cultured prostate cancer cells with the omega-3 fatty acid; monitoring transactivating ability of an androgen receptor, wherein decrease in transactivating ability is indicative of inhibitory effect by omega-3 fatty acid
03/20/2003US20030055019 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
03/20/2003US20030055018 Abrogating GTPase(Guanosine Triphosphatase)-Responsive Domain in p85 subunit of the PI3K for modulating phosphoinositide 3-kinase (PI3K) activity or phosphatidylinositol-3,4,5-P3 (PIP3) production
03/20/2003US20030054996 Contacting complex comprising a GRP94 protein with a binding agent that is immobilized to a solid phase support, to immobilize the complex to solid phase support; collecting the remaining sample; eluting the complex from solid phase support
03/20/2003US20030054988 Modified plasminogen related peptide fragments and their use as angiogenesis inhibitors
03/20/2003US20030054987 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054986 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
03/20/2003US20030054985 N-cadherin modulated migration, invasion, and metastasis
03/20/2003US20030054979 Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
03/20/2003US20030054740 High throughput mechanical rapid serial property testing of materials libraries
03/20/2003US20030054571 Multi-analyte diagnostic test for thyroid disorders
03/20/2003US20030054570 Accurate measurement mof proteins in sample; obtain sample, reduce sulfide bonds, label proteins and peptides, separate proteins and peptides from sample, digest protein mixture, quantitfy and map proteins
03/20/2003US20030054569 Detection of preferential particles in sample; provide sensitized particles, incubate with sample, expose to capillary electrophoresis, determine concentration of particles in sample
03/20/2003US20030054568 Inverse chromatography apparatus for use in the evaluation of activity between receptor and modulators; obtain sample, inject into liquid stream, pass over solid phase, pass through detector, evaluate activity, compare to control
03/20/2003US20030054561 Method and apparatus for determining concentration of NH-containing species
03/20/2003US20030054559 Method of determining presence and concentration of lipoprotein X in blood plasma and serum
03/20/2003US20030054558 Flow cytometers and detection system of lesser size
03/20/2003US20030054550 Cardiac hypertrophy factor and uses therefor
03/20/2003US20030054541 Liquid drop emitter for use in the deposition of fluids on solid supports
03/20/2003US20030054537 Genetically engineered bacteria for use as tools in the generation of heterologous proteins
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054517 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054516 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054515 Protein complex for use in the treatment and diagnosis of non-insulin dependent diabetes mellitus, nervous system and nervous system disorders
03/20/2003US20030054491 Peptide for use in the treatment of immunological, infectious and cancer disorders
03/20/2003US20030054490 Isolated human phosphatase proteins, nucleic acid molecules encoding phosphatase proteins and uses thereof
03/20/2003US20030054489 Peptide for use in the treatment of inflammation, cancer and arteriosclerosis
03/20/2003US20030054488 Goodpasture antigen binding protein
03/20/2003US20030054483 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054482 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054481 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054480 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054479 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054477 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054476 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054475 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054474 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054473 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054472 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054471 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054470 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumors and cell proliferative disorders
03/20/2003US20030054469 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054468 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054467 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054466 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054465 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054464 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054461 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054460 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054459 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054457 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054455 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors
03/20/2003US20030054452 Lysolipid for use in controlling apoptosis and treating inflammatory and innumological disorders
03/20/2003US20030054451 Nucleotide sequences coding polypeptide for use as tools in genetic engineering
03/20/2003US20030054448 T1R taste receptors and genes encoding same
03/20/2003US20030054447 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
03/20/2003US20030054441 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054434 Generation of active slide; provide aldehyde, deposit on slide, recover slide
03/20/2003US20030054433 Method for detecting oxidized forms of soluble guanylate cyclase and a method for screening for activators of soluble guanylate cyclase having oxidized heme iron
03/20/2003US20030054432 Methods and reagents for detecting endotoxin
03/20/2003US20030054431 Self assembly of sensor membranes
03/20/2003US20030054429 Dry analytical element for immunoassay
03/20/2003US20030054427 Minimum procedure system for the determination of analytes
03/20/2003US20030054426 Peptide biomarker and method of identification
03/20/2003US20030054425 High throughput screening assay systems in microscale fluidic devices
03/20/2003US20030054424 Rapid and sensitive method for measuring PCB contamination
03/20/2003US20030054423 Attachment of biomolecules to hydrophobic surfaces
03/20/2003US20030054422 Lipopolysaccharide immunoassay and test device
03/20/2003US20030054420 Nucleic acids, proteins, and antibodies
03/20/2003US20030054419 Method to determine prognosis after therapy for prostate cancer
03/20/2003US20030054418 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of lipid and cancer disorders
03/20/2003US20030054416 Test for oxidative stress using cell suspensions
03/20/2003US20030054414 Diagnostic marker for use in the diagnosis, classification and treatment of diabetes and autoimmune diseases
03/20/2003US20030054413 Bioconjugate for use in the detection and measurement of preferential biopolymers
03/20/2003US20030054412 Early diagnosis of stroke
03/20/2003US20030054408 Detection of preferential protein in sample; obtain protein sample, incubate with proteolytic agent, recover protein fragments, incubate with bindng array, detect binding pattern of peptide fragments, compare to control
03/20/2003US20030054406 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054405 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054404 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054403 Nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cancer, nervous system, viral, kidney and inflammatory diseases
03/20/2003US20030054401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054400 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054397 Methods and compositions for the detection and treatment of multiple sclerosis
03/20/2003US20030054389 Detecting antiproliferative agents; obtain cells, incubate with nucleotide sequences coding antiproliferative agents, transform cells, express sequences, monitor cell propagation, reduced propagation indicates antiproliferative agents
03/20/2003US20030054387 Metastasis-associated genes
1 ... 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 ... 3937